OTHER INFORMATION
−Removed: the quarter ended March 31, 2026, no Director or Officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”
−Removed: or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the quarter
+Added: ended June 30, 2026, no Director or Officer of the Company adopted or terminated a “Rule 10b5-1 trading
+Added: arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
1 unchanged sentence
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
−Removed: Inline XBRL Document Set
−Removed: for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.*
−Removed: Inline XBRL for the cover
−Removed: page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.*
+Added: Inline XBRL Document Set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.*
+Added: Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.*
Filed herewith.
Furnished herewith.
−Removed: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
−Removed: the undersigned thereunto duly authorized, on May 13, 2026.
+Added: Pursuant to the requirements of the Securities Exchange Act
+Added: of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on August
SUNSHINE BIOPHARMA INC.
Chief Executive Officer (principal executive officer)
−Removed: Camille Sebaaly
+Added: /s/ Camille Sebaaly
Camille Sebaaly
−Removed: Chief Financial
−Removed: Officer (principal financial and accounting officer)
+Added: Chief Financial Officer (principal financial and accounting officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.